
Insidermedia reports on July 5th, Supreme has become the master distributor of ELFBAR and LOST MARY in the United Kingdom.
Supreme is a fast-moving consumer goods manufacturer, supplier, and brand based in Manchester. The company will be supplying products from ELFBAR and LOST MARY to major retailers in the UK, including Tesco, Morrison, One Stop, and WHSmith Travel.
Supreme CEO Sandy Chadha has announced that the new distribution agreement is expected to generate revenues of £25-30 million for the fiscal year ending March 31, 2024. To support the necessary operational funding for this growth, Supreme has allocated an additional £2 million in earnings before interest, taxes, depreciation, and amortization (EBITDA).
Sandy Chada expressed his satisfaction with the significant distribution appointment, stating that it will allow their business to fully leverage its unique technological, regulatory, compliance, and quality assurance capabilities in the e-cigarette industry. Chada noted that both established and new retailers have responded positively, viewing Supreme as an ideal partner for supplying these products in the UK. He also looked forward to updating their key stakeholders on the progress made throughout the remaining time of the year.
According to reports, Supreme is a prominent distributor for the well-known disposable e-cigarette brand SKE in the United Kingdom. It also owns its own e-cigarette brand known as 88vape.
References:
【1】VAPING DISTRIBUTION SUCCESS FOR SUPREME
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.









